Genzyme Genetics Company Profile

05:12 EST 16th December 2018 | BioPortfolio

Genzyme Genetics is a leading worldwide provider of reproductive and oncology diagnostic testing, as well as genetic counseling services. As a business unit of Genzyme Corporation, Genzyme Genetics employs over 1,500 people and has eight laboratories located across the United States and operations in Europe and Japan.
Extensive Test Menu

Genzyme Genetics leadership is evidenced by its state-of-the-art menu of reproductive testing services. We offer innovative products such as CFplusTM, an extensive cystic fibrosis carrier screening test that addresses the needs of the pan-ethnic U.S. population, and an industry-leading menu of maternal serum screening tests designed to provide the critical information to pregnant patients as early and accurately as possible in their pregnancy.

Additionally, we have extensive testing experience in the areas of breast cancer, colorectal cancer, hematolymphoid and difficult-to-diagnose cases. The company leads the market in breast cancer therapeutic and prognostic analysis, providing critical information on approximately 25% of newly diagnosed breast cancer cases in the United States, and in hematology/oncology testing services, seeing 20% of newly-diagnosed cases of suspected leukemia and lymphoma in the U.S. annually.


3400 Computer Drive
United States of America


Phone: 508 898 9001
Fax: 508 389 5549

News Articles [429 Associated News Articles listed on BioPortfolio]

Genzyme Stock, PTV News: May 07, 2010

Genzyme Board approves US $2B stock repurchase and considers options for 3 divisions

Genzyme: What Makes a Great Rare Disease Company.

In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to David Meeker, President & CEO at Genzyme

New patent expiration for Genzyme drug MOZOBIL

Annual Drug Patent Expirations for MOZOBIL Mozobil is a drug marketed by Genzyme and is included in one NDA. It is available from one supplier. There are three patents protecting… The post New paten...

Sanofi Genzyme eyes major expansion in Cambridge

Sanofi Genzyme is reportedly looking to expand its footing into a bustling tech campus in the Cambridge, Mass. area.

Genzyme: Rogerio Vivaldi. Developing breakthrough therapies for uncommon and underserved medical conditions.

In this episode of PharmaTelevision News Review, filmed at Bio Conference 2013, in Chicago, USA, Fintan Walton talks to Rogerio Vivaldi from Genzyme

Sanofi Genzyme’s foray into Indian MS market should be met with caution, says GlobalData

Sanofi Genzyme — specialty care global business unit of French pharma company Sanofi — has launched its multiple sclerosis (MS) drug in India, however, according to GlobalData, it should be cautio...

News Headlines, PTV News: Feb 12, 2010

Gaucher rivals: Genzyme set to lose blockbuster monopoly Generics- no thanks: AstraZeneca chief bucks copy-cat trendGaucher rivals: Genzyme set to lose blockbuster monopoly[RELEASED 10:30 am GMT]

NICE rejects Genzyme’s Caprelsa for medullary thyroid cancer

NICE has published draft guidelines rejecting Sanofi Genzyme’s Caprelsa for treating medullary thyroid cancer (MTC) that cannot be operated on or has spread around the body.

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Cerezyme [Genzyme Corporation]

Thyrogen [Genzyme Corporation]

Renagel [Genzyme Corporation]

These highlights do not include all the information needed to use Renagel safely and effectively. See full prescribing information for Renagel. Renagel (sevelamer hydrochloride) Tablet for Oral use In...

Aldurazyme [Genzyme Corporation]

These highlights do not include all the information needed to use ALDURAZYME safely and effectively. See full prescribing information for ALDURAZYME. ALDURAZYME (laronidase)Solution for intravenous in...

Carticel [Genzyme Corporation]

These highlights do not include all the information needed to use Carticel safely and effectively. See full prescribing information for Carticel. Carticel® (autologous cultured chondrocytes) For Auto...

PubMed Articles [563 Associated PubMed Articles listed on BioPortfolio]

Genetics is the logic of life (at least of mine).

I retrace my path from math to medicine to biochemistry to yeast genetics, my focus on infectious diseases of yeast and finally prions. My discovery of yeast prions relied on my particular focus on th...

Response to Nakaguma et al.

Correction: Moss genetics and the way forward.

[This corrects the article DOI: 10.1371/journal.pgen.1007330.].

Genome-first findings require precision phenotyping.

Collaborations in medical genetics: 10-year history of an ongoing Vietnamese-North American Collaboration.

Clinical Trials [353 Associated Clinical Trials listed on BioPortfolio]

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)

The purpose of this research study is to compare subject comfort during and after injection with NADGL and Captique® Injectable Gel, in the nasolabial folds. Captique® is an FDA-approve...

Extension Study of Long-Term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies.

This extension study was to monitor the long-term safety and efficacy of rhGAA treatment in a single patient with infantile-onset Pompe disease who were previously treated with rhGAA in a ...

Companies [55 Associated Companies listed on BioPortfolio]


Genzyme is one of the world’s leading biotechnology companies. Its more than 9,000 employees work in countries throughout the world and are united by a common goal: to make a major positive impact o...

Genzyme, a Sanofi Company

Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals t...

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Genzyme Corp.

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company ha...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

More Information about "Genzyme Genetics" on BioPortfolio

We have published hundreds of Genzyme Genetics news stories on BioPortfolio along with dozens of Genzyme Genetics Clinical Trials and PubMed Articles about Genzyme Genetics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genzyme Genetics Companies in our database. You can also find out about relevant Genzyme Genetics Drugs and Medications on this site too.

Quick Search


Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cystic Fibrosis
Affecting over 8,500 people in the UK, Cystic Fibrosis (CF) is one of the UK's most common life-threatening inherited diseases. Around half of the CF population can expect to live over 38 years, although improvements in treatments mean a baby born ...

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...

Corporate Database Quicklinks

Searches Linking to this Company Record